Trump's new tariff plan for imported generic medicines risks higher healthcare costs for Americans and poses significant challenges for Indian pharmaceutical exports.
Novo Nordisk sues Eli Lilly, alleging false advertising in weight-loss medication ads, claiming misleading comparisons between their respective drug products.